What this record covers
DeveloperAppliedVR
GeographyUnited States
ModalitiesVR
MaturityCommercial medical device
Last reviewed2026-07-23
Clinical areas and use cases
Specialties
Pain management
Use cases
Therapy supportHome care
Regulatory context
United States: FDA Class II device record K243417. Regulatory status is region- and date-specific.
This is source-linked metadata, not an AVRMD endorsement or medical recommendation.On the FDA's AR/VR device list (3)
- RelieVRx (Pico G3)K251519 · Neurology · 2025-08-13
- RelieVRxK243417 · Neurology · 2024-12-04
- EaseVRxDEN210014 · Neurology · 2021-11-16
Primary source
FDA 510(k) summary K243417Description is limited to the official indication and device summary.Questions about this record
Ask the members who have used or built something like it, or post a question · see questions in Pain management.